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Abstract 
The aim of the present study was to investigate the antibacterial activities of 10 different herbal medicinal 
products sourced from the traditional medicine sales outlets and at the traditional medical trade fare in Imo State 
of Nigeria. The streaking and the agar-well diffusion methods were adopted for the inoculation of test organisms 
and sensitivity testing respectively. The antibacterial activities of the products varied considerably. From the 
screening experiments, product H showed the best antibacterial activity while production B had the least 
antibacterial activity by inhibiting only Escherichia coli with zone diameter of 16.75+0.01mm and MIC/MBC 
index of 0.50. The highest zone of inhibition was obtained with product D against Staphylococcus aeurus 
(26.45+0.06mm) and the MIC value of 50.0mg/ml. Pseudomonas aeruginosa showed a high level of resistance to 
the products and was slightly inhibited by only product G with zone diameter of 3.78+0.14mm. There is need to 
standardize, monitor and regulate the product of herbal remedies available in the Nigerian markets.  
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1. Introduction 
Nature is one way or the other has provided answers for every illness and disease conditions known to man. 
“Plants” have been outstanding in this regard (R’ios and Recio, 2005). The use of medicinal plants for the 
treatment of illness is in practice in many parts of the world. Every country has its own indigenous medicinal 
system (Awosika, 1995). Herbal therapy is becoming increasingly popular among patients and physicians. Many 
herbal preparations are marketed to the public for various ailments (Krim et al, 2002). Currently especially in the 
United State, herbal products as not regulated as they are considered dietary supplements (Routh and Bhowmik, 
1999). Therefore, there is no standardization of active ingredients, purity or concentration. There is also no 
regulations governing which herbs can be marketed for various ailments (Routh and Bhowmik, 1999). This has 
made learning about and using these treatments challenging. Information compiled in a practical fashion may 
enable more patients to benefit from these treatments currently used worldwide (Routh and Bhowmik, 1999). 
The indiscriminate use of antibiotics has resulted in many bacterial pathogens rapidly becoming resistant to a 
number of the originally discovered antimicrobial drugs (Barbour et al, 2004). The antimicrobial compounds 
found in plants may prevent bacterial infections by different mechanisms than the commercial antibiotics and 
therefore may have clinical value in treating resistant microorganism strains (Eloff, 1999). There is, thus, a 
continuous search for new antibiotics and medicinal plants may offer a new source of antibacterial agents. 
Combination of two or more antibiotics with different mechanisms of action are sometimes tested in an attempt 
to improve efficacy through synergy and prevent the development of antibiotic resistance (Beringer, 1999). 
Many potential antimicrobial compounds are not singularly effective, and in combination with another 
compound, could possibly improve antimicrobial efficacy through synergism.  
 Moreover, the increase cost of new and more effective antimicrobial remedies (Salie, et al 1996) together with 
their side effects and lack of health care facilities in some rural areas (Griggs et al, 2001), makes the search for 
safer, more effective and affordable alternative remedies imperative. 
The majority of medicinal plant consumers purchase herbal material from markets. Stafford et al (2004), state 
that approximately 450 plant species are sold in large volumes from herbal trade markets. These markets 
generally have poor physical conditions and infrastructures with a lack of storage facilities resulting in spoilage 
of plant material (Stafford et al, 2004, Mander, 1997). These poor conditions lead to wastage and a decrease in 
the quality of plant materials. Fennell et al (2004), state that Africa is fairly behind with regard to the control and 
development of the medicinal plant industry and researchers are, thus, focusing on several aspects needed for the 
development of the medicinal plant trade in Africa. 
2.0 Materials and methods 
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2.1 Collection of Samples:  
The traditionally (locally) made concoctions were collected from the herbalist at the tradomedical trade fare of 
the different zones in Imo State. The concoction collected includes those for the treatment of typhoid fever 
(product A and B-Eucalyptus offensinalis and Azadirichta indica) Diarrhoea (product C and D-Psidum govaja 
and Anacardium occidentale) Bronchitis (product E and F-Cocos nucifera and Mangifera indica) urinary tract 
infection (product G and H-Ficus asperifolia and Alluim sativum) and venereal diseases (product I and J-
Terminalis catappa and Musa paradisiaca). 
2.2 Concentration of the herbal remedies and storage 
About 200ml of the herbal remedies of various plants were evaporated to dryness in a steady air current for 
24hours. The fine residues were exposed to U.V. rays for 18 hours after which it was checked for sterility by 
streaking on nutrient agar plate. The residues were stored in different clean sterile labeled containers until they 
were needed. 
2.3 Collection, purification, confirmation and storage of the test organisms 
Clinical bacterial isolates were obtained from Federal Medical Centre Owerri microbiology laboratory. The 
organisms include staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Proteus mirabilis and 
Pseudomones aeruginosa. These organisms were purified by re-isolating in Hinton agar and was confirmed after 
characterization by standard bacteriological methods (Cheesbrough, 2004). The stock cultures were stored at 4
o
C 
in nutrient agar slants. 
2.4 Standardization of inoculums:  
The Mcfarland nepholometer standard was prepared according to the National committee for clinical laboratory 
standards (NCCLS, 1998). The final inoculum was adjusted to 1.0X10
6
cfu/ml for gram positive bacteria and 
5X10
5
cfu/ml for gram negative bacteria. 
2.5 Sensitivity screening of test samples by agar well diffusion method at 200mg/ml:  
This was done following the method describes by Okoli et al (1988). The inoculum of each of the test organisms 
was seeded onto sterile Muller Hinton Agar plates. Subsequently, 100µl of 200mg/ml concentration of the 
various concoction extracts was separately introduced in dublicate well of the agar culture. The plates were 
allowed to stand for 1 hour to allow diffusion of the extracts to take place and then incubated for 37
o
C for 24 
hours. The zones of inhibition were recorded to the nearest millimeter (mm). 
2.6 Determination of minimum inhibitory concentration and minimum bactericidal concentration of 
the test samples:   
 
The MIC was determined by Macro-Broth Dilution techniques as specified by NCCLS (1998). A two fold serial 
dilution of the reconstituted extract was prepared in a Muller Hinton Broth. Each dilution was seeded with 100 
µl of the standardized suspension of the test organisms (i.e 1.0X10
6
cfu/ml for Gm +ve and 5.0X10
5
 cfu/ml for 
Gm-ve bacteria). All the cultures were incubated for 24 hours at 37
o
C. MIC was determined as lowest 
concentration of the test samples that showed visible growth. For MBC, nine 0.1ml volume of Broth from each 
macro-Broth MIC testing showing no bacterial growth was taken and incubated in a sterile Muller Hinton agar at 
37
o
C for 24 hours. The MBC was determined as the least concentration showing no growth on subculture. 
2.7 Statistical analysis 
Paried sample T-test was conducted to analyze the diameter of the zone of inhibition. Values are reported as 
means of duplicate determination + standard deviation. 
3. Results 
There was a significant difference (P<0.05) between the mean zone inhibition of the herbal remedies. Product H 
had antibacterial activities against the majority of the test organisms with mean zone of inhibition ranging from 
12.16+0.02mm to 25.57+0.13mm. However the highest zone of inhibition of 26.45+0.06mm was produced 
against staphylococcus aureus by product D. Only product G had activity against Pseudomonas aeruginosa with 
zone diameter of 3.78+0.14mm. This is shown in Table 1. Product B had the least antibacterial activity. It only 
inhibited E.coli with zone diameter of 16.75+0.01. The minimum inhibitory concentration (MIC) and minimum 
bacterdical concentration (MBC) of the extracts of the herbal remedies are shown in Table 2. The activity index 
measured as ratio of the MBC to MIC showed that product H had an index of 1.00 indicating that it had a 
bacteridical effect against Escherichia coli. The rest of the products had a bacteriostatic effect with activity index 
of less than 1.00. The MIC values of these extracts ranged from 50-100. The extracts of product E, G and H had 
bactericidal effect against staphylococcus aureus with MBC value ranging from 50mg/ml to 100mg/ml. Product 
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B exhibited no effect while the rest were bacteriostatic against staphylococcus aureus (index of 0.50). 
Only product H showed a bactericidal effect against Streptococcus pneumoniae with an MBC value of 
100mg/ml. Products G, H and I exhibited a bacteriostatic effect against Proteus, mirabilis with MIC value of 50-
100mg/ml while product F had a bactericidal effect against Proteus mirabilis with an MBC value of 25mg/ml. 
Pseudomonas aeruginosa showed a high level of resistance to all the products. 
4. DISCUSSION 
The efficacy pattern of the herbal remedies used in the treatment of typhoid fever, diarrhea, bronchitis, urinary 
tract infection and venereal diseases, revealed varying level of antibacterial activities of each batch of traditional 
herbal remedy on the test hospital isolates. 
Herbal drug preparation methods by traditional healers are mainly by maceration, infusion and decoction. 
“Drugs” prepared in this way most likely extract polysaccharides that could be responsible for mucosal layer 
protection by binding to the toxin when administers orally. During storage, preparations may undergo 
fermentation that enables enzymes activation or formation of decomposition products that in turn may kill the 
organism or neutralize the toxins when the drug is taken (Manegesi et al, 2008). 
Varying levels of sensitivity ranging from resistance to slight, moderate and heavy inhibition were observed. 
This difference of activity appears to be directly related to the quantitative and/or qualitative diversity of the 
compounds that are being accumulated by the products investigated. It is believed that plants which are rich in a 
wide variety of secondary metabolites belonging to chemical classes such a tannins, terpenoids, alkaloids and 
polyphenols are generally superior in their antimicrobial activities (Cowan, 1999). This suggests that the strength 
of biological activities of a natural product is dependent on the diversity and quantity of such constituents (Geyid 
et al, 2005). 
The inconsistency in the level of sensitivity could also be associated with difference in the preparation of each 
batch, as there are no known manufacturing standard for the product of traditional herbal remedies. This lack of 
standard may affect the quality of plant part used, the type of diluents/solvents use. The treatment involved in 
herbal remedy preparation that is, whether heating or alcohol was adopted to enhance the extraction and whether 
other medicinal plants were added may have a contribution. The type and level of preparation are also affected 
by secrecy which is an obvious characteristics of traditional medical practice in Africa. Aside from the similarly 
in preparation and standardization, the age of the herbal remedy also has to do with the efficacy of the herbal 
products. 
5. CONCLUSION 
On the basis of the results, the antibacterial activities of the herbal remedies shows varying level of sensitivity 
which is as a result of lack of standardized protocol for the preparation of these herbal remedies and also the age 
of the herbal remedy. Traditional herbal council that will act as a clearing and regulating outfit to standardized, 
monitor and regulate the production of herbal remedies should be instituted. 
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Table 1: Mean zone inhibition (mm) of the extracts of the herbal remedies 
Product 
code 
1 2 3 4 5 
A 8.63±0.03 9.04±0.02 4.69±0.01 2.28±0.08 0.00±0.00 
B 16.75±0.01 0.35±0.01 0.00±0.00 0.00±0.00 0.00±0.00 
C 4.56±0.02 1.57±0.47 1.09±0.01 0.00±0.00 0.00±0.00 
D 20.14±0.02 26.45±0.06 6.77±0.02 0.72±0.08 0.00±0.00 
E 9.47±0.01 6.81±0.02 5.31±0.13 0.00±0.00 0.00±0.00 
F 13.14±003 8.71±0.03 0.97±0.04 10.31±0.02 0.00±0.00 
G 10.27±0.01 4.68±0.00 11.97±0.03 0.00±0.00 3.78±0.14 
H 22.68±0.02 13.74±0.01 12.16±0.02 25.57±0.13 0.00±0.00 
I 18.17±0.02 4.86±0.01 0.00±0.00 4.66±0.04 0.00±0.00 
J 4.20±0.01 12.02±0.01 1.13±0.01 0.00±0.00 0.00±0.00 
Key: 1 = Escherichia coli, 2 = Staphylococcus aureus, 3 = Streptococcus pneumoniae, 4 = Proteus mirabilis, 5 = 
Pseudomonas aeruginosa 
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Table 2: Minimum inhibitory and minimum bactericidal concentration (MIC and MBC) of the herbal remedies 
against the test organisms 
Product code Organisms MIC MBC MIC/MBC 
 
 
A 
1 25 25 1.00 
2 100 >200 <0.50 
3 100 >200 <0.50 
4 >200 >200 <0.50 
5 >200 >200 <0.50 
 
 
B 
1 25 50 0.50 
2 >200 >200 <0.50 
3 >200 >200 <0.50 
4 >200 >200 <0.50 
5 >200 >200 <0.50 
 
 
C 
1 100 >200 <0.50 
2 100 >200 <0.50 
3 >200 >200 <0.50 
4 >200 >200 <0.50 
5 >200 >200 <0.50 
D 1 25 50 0.50 
2 50 >200 <0.50 
3 50 >200 <0.50 
4 >200 >200 <0.50 
5 >200 >200 <0.50 
 
E 
1 100 >200 <0.50 
2 50 100 0.50 
3 100 >200 <0.50 
4 >200 >200 <0.50 
5 >200 >200 <0.50 
 
 
F 
1 25 >200 <0.50 
2 100 >200 <0.50 
3 >200 >200 <0.50 
4 12.50 25 0.50 
5 >200 >200 <0.50 
 
 
G 
1 25 50 0.50 
2 25 50 0.50 
3 25 >200 <0.50 
4 100 >200 <0.50 
5 >200 >200 <0.50 
 
 
H 
1 6.25 >200 <0.50 
2 50 50 1.00 
3 50 100 0.50 
4 50 >200 <0.50 
5 >200 >200 <0.50 
 
 
I 
1 25 >200 <0.50 
2 100 >200 <0.50 
3 >200 >200 <0.50 
4 100 >200 <0.50 
5 >200 >200 <0.50 
 
 
J 
1 50 >200 <0.50 
2 50 >200 <0.50 
3 50 >200 <0.50 
4 >200 >200 <0.50 
5 >200 >200 <0.50 
Key: 1 = Escherichia coli, 2 = Staphylococcus aureus, 3 = Streptococcus pneumoniae, 4 = Proteus mirabilis, 5 = 
Pseudomonas aeruginosa 
This academic article was published by The International Institute for Science, 
Technology and Education (IISTE).  The IISTE is a pioneer in the Open Access 
Publishing service based in the U.S. and Europe.  The aim of the institute is 
Accelerating Global Knowledge Sharing. 
 
More information about the publisher can be found in the IISTE’s homepage:  
http://www.iiste.org 
 
CALL FOR PAPERS 
The IISTE is currently hosting more than 30 peer-reviewed academic journals and 
collaborating with academic institutions around the world.  There’s no deadline for 
submission.  Prospective authors of IISTE journals can find the submission 
instruction on the following page: http://www.iiste.org/Journals/ 
The IISTE editorial team promises to the review and publish all the qualified 
submissions in a fast manner. All the journals articles are available online to the 
readers all over the world without financial, legal, or technical barriers other than 
those inseparable from gaining access to the internet itself. Printed version of the 
journals is also available upon request from readers and authors.  
IISTE Knowledge Sharing Partners 
EBSCO, Index Copernicus, Ulrich's Periodicals Directory, JournalTOCS, PKP Open 
Archives Harvester, Bielefeld Academic Search Engine, Elektronische 
Zeitschriftenbibliothek EZB, Open J-Gate, OCLC WorldCat, Universe Digtial 
Library , NewJour, Google Scholar 
 
 
